CDSCO panel grants GSK's proposal for Updation of Package Insert of Infanrix Hexa Vaccine Dr. Divya Colin22 March 2023 6:00 PM ISTNew Delhi: Pharmaceutical major GSK has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Roche gets CDSCO panel nod to import, market anticancer Drug Polatuzumab vedotin Dr. Divya Colin21 March 2023 6:00 PM ISTNew Delhi: In a significant development, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organization (CDSCO)...
CDSCO issued show cause notice to 31 firms following concerns over e-pharmacies: MoS Health Bharati Pravin Pawar Farhat Nasim20 March 2023 5:33 PM ISTCases concerning the quality of drugs, when reported, was taken up with the State Licensing Authority (SLA) concerned for necessary action under the...
FICCI jumps in support of e-pharmacies, writes to Health Ministry of show-cause notice Ruchika Sharma19 March 2023 12:30 PM ISTThe letter written by FICCI has also mentioned that there are no valid reasons that E-Pharmacies shouldn't operate in the India market place.
Presence of pharmacist mandatory in retail medical stores: DCGI to states, UTs drug controllers, PCI Ruchika Sharma18 March 2023 1:30 PM ISTNew Delhi: India's drug regulator DCGI has written to drug controllers of all states and Union territories and the Pharmacy Council of India asking...
Conduct Phase III CT : CDSCO panel tells AstraZeneca for anticancer drug Olaparib Film coated Tablet Dr. Divya Colin17 March 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under Central Drug Standard Control Organization (CDSCO) has opined the drug major...
AstraZeneca Gets CDSCO Panel nod to import, market Trastuzumab deruxtecan for breast cancer Dr. Divya Colin16 March 2023 6:00 PM ISTNew Delhi: Granting the local Phase III clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Continue CT with 30 ongoing Indian subjects: CDSCO panel tells Novo-Nordisk on Insulin Icodec Dr. Divya Colin15 March 2023 6:00 PM ISTNew Delhi: Based on the safety data of 30 Indian subjects in the global clinical trial of Insulin Icodec, the Subject Expert Committee (SEC)...
GSK gets CDSCO Panel nod to import, market anticancer drug Dostarlimab Susmita Roy14 March 2023 6:00 PM ISTNew Delhi: Highlighting the unmet medical need in the country, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
CDSCO Panel Rejects Pfizer's Proposal to Waive Phase IV CT of Antimicrobial FDC Dr. Divya Colin13 March 2023 6:00 PM ISTNew Delhi: Highlighting that there is no unmet need for a Phase IV clinical trial study waiver, the Subject Expert Committee (SEC) functional under...
Synokem gets CDSCO panel nod to study Dyhydogestrone as part of Assisted Reproductive Technology Dr. Divya Colin12 March 2023 6:00 PM ISTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug...
Boehringer Ingelheim gets CDSCO panel nod to market Spesolimab indicated for generalized pustular psoriasis Dr. Divya Colin11 March 2023 6:00 PM ISTNew Delhi: Granting the local clinical trial waiver, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
